Keyphrases
Point mutation
100%
Renal Cell Carcinoma
100%
Von Hippel-Lindau Disease
100%
Paraneoplastic
100%
Hypoxia-inducible Transcription Factor
100%
Erythrocytosis
100%
Erythropoietin
42%
Tumor
14%
Gene Targeting
14%
Molecular Analysis
14%
Structural Change
14%
Myocardial Infarction
14%
Tumor Suppressor Gene
14%
Messenger RNA (mRNA)
14%
Renal Cancer
14%
Clear Cell Renal Cell Carcinoma (ccRCC)
14%
Von Hippel-Lindau
14%
Von Hippel-Lindau Tumor Suppressor
14%
Regulatory Subunit
14%
Hemoglobin
14%
Thrombotic
14%
Sequence Analysis
14%
Proteasomal Degradation
14%
Initial Manifestation
14%
Serum Erythropoietin Level
14%
Amino Acid Exchange
14%
Transcription Factor Binding
14%
Transcription Factor Targets
14%
Tumor Tissue
14%
Binding Region
14%
Medicine and Dentistry
Hypoxia
100%
Clear Cell Renal Cell Carcinoma
100%
Transcription Factors
100%
Point Mutation
100%
Erythrocytosis
100%
Erythropoietin
57%
Neoplasm
28%
Amino Acid
14%
Messenger RNA
14%
Myocardial Infarction
14%
Kidney Cancer
14%
Tumor Suppressor Gene
14%
Clear Cell
14%
Sequence Analysis
14%
Protein Sequencing
14%
Renal Cell Carcinoma
14%
Von Hippel-Lindau Tumor Suppressor
14%
Pharmacology, Toxicology and Pharmaceutical Science
Transcription Factors
100%
Hypoxia
100%
Renal Cell Carcinoma
100%
Erythrocytosis
100%
Erythropoietin
57%
Neoplasm
28%
Messenger RNA
14%
Amino Acid
14%
Heart Infarction
14%
Kidney Cancer
14%
Tumor Suppressor Protein
14%
Von Hippel Lindau Disease
14%
Biochemistry, Genetics and Molecular Biology
Transcription Factors
100%
Point Mutation
100%
Erythropoietin
57%
Amino Acids
14%
Messenger RNA
14%
Protein Sequencing
14%
Tumor Suppressor Gene
14%
Von Hippel-Lindau Tumor Suppressor
14%